Family Office Research’s Avantis US Equity ETF AVUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.3M Sell
111,428
-953
-0.8% -$117K 5.35% 5
2026
Q1
$12.5M Buy
112,381
+976
+0.9% +$112K 5.43% 6
2025
Q4
$12.6M Sell
111,405
-639
-0.6% -$70.4K 5.14% 8
2025
Q3
$12.2M Sell
112,044
-1,043
-0.9% -$109K 5.33% 8
2025
Q2
$11.4M Buy
113,087
+16,098
+17% +$1.51M 5.39% 8
2025
Q1
$8.96M Buy
96,989
+15,240
+19% +$1.48M 4.36% 8
2024
Q4
$7.92M Buy
+81,749
New +$8.03M 3.47% 8

Other funds holding AVUS

Family Office Research's AVUS Position: Q2 2026 in Review

Family Office Research reduced its Avantis US Equity ETF (AVUS) stake by 0.85% in Q2 2026, selling an estimated $117K and leaving 111,428 shares worth $14.3M. The position accounts for 5.35% of the portfolio, ranked #5.

Family Office Research first reported a position in AVUS in Q4 2024 and has held it in 7 quarters since. 510 funds tracked by Wall St. Rank hold AVUS as of Q2 2026.

  • Family Office Research held 111,428 shares of Avantis US Equity ETF worth $14.3M as of Q2 2026.
  • Family Office Research sold 953 Avantis US Equity ETF shares in Q2 2026, an estimated $117K.
  • Avantis US Equity ETF made up 5.35% of Family Office Research's portfolio in Q2 2026, its #5 holding.
  • Family Office Research first reported a position in Avantis US Equity ETF in Q4 2024 and has held it in 7 quarters since.
  • 510 funds tracked by Wall St. Rank held Avantis US Equity ETF as of Q2 2026.

Based on Family Office Research's 13F filing for Q2 2026, filed 27 Jul 2026.